PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
TransMedics Group, Inc. (TMDX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS89377M1099
CUSIP89377M109
SectorHealthcare
IndustryMedical Devices

Highlights

Market Cap$2.76B
EPS-$0.77
Revenue (TTM)$241.62M
Gross Profit (TTM)$65.27M
EBITDA (TTM)$8.66M
Year Range$36.42 - $99.63
Target Price$99.40
Short %21.18%
Short Ratio8.10

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


TransMedics Group, Inc.

Popular comparisons: TMDX vs. VOO, TMDX vs. SPY, TMDX vs. BTC-USD, TMDX vs. DXCM, TMDX vs. NVDA, TMDX vs. FTNT

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in TransMedics Group, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%50.00%100.00%NovemberDecember2024FebruaryMarchApril
109.42%
18.82%
TMDX (TransMedics Group, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

TransMedics Group, Inc. had a return of 9.60% year-to-date (YTD) and -2.50% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date9.60%5.05%
1 month22.09%-4.27%
6 months109.42%18.82%
1 year-2.50%21.22%
5 years (annualized)N/A11.38%
10 years (annualized)N/A10.42%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20248.67%-4.86%-9.39%
2023-16.58%-31.54%101.92%4.29%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of TMDX is 57, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.

The Risk-Adjusted Performance Rank of TMDX is 5757
TransMedics Group, Inc.(TMDX)
The Sharpe Ratio Rank of TMDX is 5454Sharpe Ratio Rank
The Sortino Ratio Rank of TMDX is 6262Sortino Ratio Rank
The Omega Ratio Rank of TMDX is 6060Omega Ratio Rank
The Calmar Ratio Rank of TMDX is 5858Calmar Ratio Rank
The Martin Ratio Rank of TMDX is 5454Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for TransMedics Group, Inc. (TMDX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


TMDX
Sharpe ratio
The chart of Sharpe ratio for TMDX, currently valued at 0.13, compared to the broader market-2.00-1.000.001.002.003.000.13
Sortino ratio
The chart of Sortino ratio for TMDX, currently valued at 0.88, compared to the broader market-4.00-2.000.002.004.000.88
Omega ratio
The chart of Omega ratio for TMDX, currently valued at 1.10, compared to the broader market0.501.001.501.10
Calmar ratio
The chart of Calmar ratio for TMDX, currently valued at 0.15, compared to the broader market0.001.002.003.004.005.000.15
Martin ratio
The chart of Martin ratio for TMDX, currently valued at 0.35, compared to the broader market0.0010.0020.0030.000.35
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.81, compared to the broader market-2.00-1.000.001.002.003.001.81
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.64, compared to the broader market-4.00-2.000.002.004.002.64
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.31, compared to the broader market0.501.001.501.32
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.38, compared to the broader market0.001.002.003.004.005.001.38
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.21, compared to the broader market0.0010.0020.0030.007.21

Sharpe Ratio

The current TransMedics Group, Inc. Sharpe ratio is 0.13. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00NovemberDecember2024FebruaryMarchApril
0.13
1.81
TMDX (TransMedics Group, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


TransMedics Group, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2024FebruaryMarchApril
-9.95%
-4.64%
TMDX (TransMedics Group, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the TransMedics Group, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the TransMedics Group, Inc. was 73.69%, occurring on Feb 23, 2022. Recovery took 113 trading sessions.

The current TransMedics Group, Inc. drawdown is 9.95%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-73.69%Mar 23, 2021234Feb 23, 2022113Aug 5, 2022347
-65.47%May 23, 2019205Mar 16, 2020228Feb 9, 2021433
-61.76%Jul 19, 202373Oct 30, 2023
-29.9%Sep 13, 202224Oct 14, 202215Nov 4, 202239
-20.34%Apr 24, 202325May 26, 202330Jul 12, 202355

Volatility

Volatility Chart

The current TransMedics Group, Inc. volatility is 16.63%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%NovemberDecember2024FebruaryMarchApril
16.63%
3.30%
TMDX (TransMedics Group, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of TransMedics Group, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items